REPORT ID 3656

Global Human Vaccines Sales Market Report 2017

Publish Date
14-Dec-17
Pages
116
Format
Electronic (PDF)

In this report, the global Human Vaccines market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report split global into several key Regions, with sales (), revenue (Million USD), market share and growth rate of Human Vaccines for these regions, from 2012 to 2022 (forecast), covering
    United States
    China
    Europe
    Japan
    Southeast Asia
    India

Global Human Vaccines market competition by top manufacturers/players, with Human Vaccines sales volume, Price (), revenue (Million USD) and market share for each manufacturer/player; the top players including
    AstraZeneca
    Bavarian Nordic
    Bharat Biotech
    CSL Limited
    Emergent BioSolutions, Inc.
    GlaxoSmithKline plc
    Johnson & Johnson
    Merck & Co., Inc.
    Mymetics
    Novartis AG
    Pfizer, Inc.
    Sanofi
    Shenzhen Kangtai Biological Products Co., Ltd.
    Takeda Pharmaceutical Company Limited.
On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
    Pneumococcal
    Influenza
    Hepatitis
    HPV
    Meningococcal
    Rotavirus
    Measles
    Typhoid
    Combination
On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including
    Pediatrics
    Adolescents
    Adults
    Geriatrics

If you have any special requirements, please let us know and we will offer you the report as you want.

 
			   
Table of Contents

Global Human Vaccines Sales Market Report 2017
1 Human Vaccines Market Overview
    1.1 Product Overview and Scope of Human Vaccines
    1.2 Classification of Human Vaccines by Product Category
        1.2.1 Global Human Vaccines Market Size (Sales) Comparison by Type (2012-2022)
        1.2.2 Global Human Vaccines Market Size (Sales) Market Share by Type (Product Category) in 2016
        1.2.3 Pneumococcal
        1.2.4 Influenza
        1.2.5 Hepatitis
        1.2.6 HPV
        1.2.7 Meningococcal
        1.2.8 Rotavirus
        1.2.9 Measles
        1.2.10 Typhoid
        1.2.11 Combination
    1.3 Global Human Vaccines Market by Application/End Users
        1.3.1 Global Human Vaccines Sales (Volume) and Market Share Comparison by Application (2012-2022)
        1.3.2 Pediatrics
        1.3.3 Adolescents
        1.3.4 Adults
        1.3.5 Geriatrics
    1.4 Global Human Vaccines Market by Region
        1.4.1 Global Human Vaccines Market Size (Value) Comparison by Region (2012-2022)
        1.4.2 United States Human Vaccines Status and Prospect (2012-2022)
        1.4.3 China Human Vaccines Status and Prospect (2012-2022)
        1.4.4 Europe Human Vaccines Status and Prospect (2012-2022)
        1.4.5 Japan Human Vaccines Status and Prospect (2012-2022)
        1.4.6 Southeast Asia Human Vaccines Status and Prospect (2012-2022)
        1.4.7 India Human Vaccines Status and Prospect (2012-2022)
    1.5 Global Market Size (Value and Volume) of Human Vaccines (2012-2022)
        1.5.1 Global Human Vaccines Sales and Growth Rate (2012-2022)
        1.5.2 Global Human Vaccines Revenue and Growth Rate (2012-2022)

2 Global Human Vaccines Competition by Players/Suppliers, Type and Application
     2.1 Global Human Vaccines Market Competition by Players/Suppliers
        2.1.1 Global Human Vaccines Sales and Market Share of Key Players/Suppliers (2012-2017)
        2.1.2 Global Human Vaccines Revenue and Share by Players/Suppliers (2012-2017)
    2.2 Global Human Vaccines (Volume and Value) by Type
        2.2.1 Global Human Vaccines Sales and Market Share by Type (2012-2017)
        2.2.2 Global Human Vaccines Revenue and Market Share by Type (2012-2017)
    2.3 Global Human Vaccines (Volume and Value) by Region
        2.3.1 Global Human Vaccines Sales and Market Share by Region (2012-2017)
        2.3.2 Global Human Vaccines Revenue and Market Share by Region (2012-2017)
    2.4 Global Human Vaccines (Volume) by Application

3 United States Human Vaccines (Volume, Value and Sales Price)
    3.1 United States Human Vaccines Sales and Value (2012-2017)
        3.1.1 United States Human Vaccines Sales and Growth Rate (2012-2017)
        3.1.2 United States Human Vaccines Revenue and Growth Rate (2012-2017)
        3.1.3 United States Human Vaccines Sales Price Trend (2012-2017)
    3.2 United States Human Vaccines Sales Volume and Market Share by Players
    3.3 United States Human Vaccines Sales Volume and Market Share by Type
    3.4 United States Human Vaccines Sales Volume and Market Share by Application

4 China Human Vaccines (Volume, Value and Sales Price)
    4.1 China Human Vaccines Sales and Value (2012-2017)
        4.1.1 China Human Vaccines Sales and Growth Rate (2012-2017)
        4.1.2 China Human Vaccines Revenue and Growth Rate (2012-2017)
        4.1.3 China Human Vaccines Sales Price Trend (2012-2017)
    4.2 China Human Vaccines Sales Volume and Market Share by Players
    4.3 China Human Vaccines Sales Volume and Market Share by Type
    4.4 China Human Vaccines Sales Volume and Market Share by Application

5 Europe Human Vaccines (Volume, Value and Sales Price)
    5.1 Europe Human Vaccines Sales and Value (2012-2017)
        5.1.1 Europe Human Vaccines Sales and Growth Rate (2012-2017)
        5.1.2 Europe Human Vaccines Revenue and Growth Rate (2012-2017)
        5.1.3 Europe Human Vaccines Sales Price Trend (2012-2017)
    5.2 Europe Human Vaccines Sales Volume and Market Share by Players
    5.3 Europe Human Vaccines Sales Volume and Market Share by Type
    5.4 Europe Human Vaccines Sales Volume and Market Share by Application

6 Japan Human Vaccines (Volume, Value and Sales Price)
    6.1 Japan Human Vaccines Sales and Value (2012-2017)
        6.1.1 Japan Human Vaccines Sales and Growth Rate (2012-2017)
        6.1.2 Japan Human Vaccines Revenue and Growth Rate (2012-2017)
        6.1.3 Japan Human Vaccines Sales Price Trend (2012-2017)
    6.2 Japan Human Vaccines Sales Volume and Market Share by Players
    6.3 Japan Human Vaccines Sales Volume and Market Share by Type
    6.4 Japan Human Vaccines Sales Volume and Market Share by Application

7 Southeast Asia Human Vaccines (Volume, Value and Sales Price)
    7.1 Southeast Asia Human Vaccines Sales and Value (2012-2017)
        7.1.1 Southeast Asia Human Vaccines Sales and Growth Rate (2012-2017)
        7.1.2 Southeast Asia Human Vaccines Revenue and Growth Rate (2012-2017)
        7.1.3 Southeast Asia Human Vaccines Sales Price Trend (2012-2017)
    7.2 Southeast Asia Human Vaccines Sales Volume and Market Share by Players
    7.3 Southeast Asia Human Vaccines Sales Volume and Market Share by Type
    7.4 Southeast Asia Human Vaccines Sales Volume and Market Share by Application

8 India Human Vaccines (Volume, Value and Sales Price)
    8.1 India Human Vaccines Sales and Value (2012-2017)
        8.1.1 India Human Vaccines Sales and Growth Rate (2012-2017)
        8.1.2 India Human Vaccines Revenue and Growth Rate (2012-2017)
        8.1.3 India Human Vaccines Sales Price Trend (2012-2017)
    8.2 India Human Vaccines Sales Volume and Market Share by Players
    8.3 India Human Vaccines Sales Volume and Market Share by Type
    8.4 India Human Vaccines Sales Volume and Market Share by Application

9 Global Human Vaccines Players/Suppliers Profiles and Sales Data
    9.1 AstraZeneca
        9.1.1 Company Basic Information, Manufacturing Base and Competitors
        9.1.2 Human Vaccines Product Category, Application and Specification
            9.1.2.1 Product A
            9.1.2.2 Product B
        9.1.3 AstraZeneca Human Vaccines Sales, Revenue, Price and Gross Margin (2012-2017)
        9.1.4 Main Business/Business Overview
    9.2 Bavarian Nordic
        9.2.1 Company Basic Information, Manufacturing Base and Competitors
        9.2.2 Human Vaccines Product Category, Application and Specification
            9.2.2.1 Product A
            9.2.2.2 Product B
        9.2.3 Bavarian Nordic Human Vaccines Sales, Revenue, Price and Gross Margin (2012-2017)
        9.2.4 Main Business/Business Overview
    9.3 Bharat Biotech
        9.3.1 Company Basic Information, Manufacturing Base and Competitors
        9.3.2 Human Vaccines Product Category, Application and Specification
            9.3.2.1 Product A
            9.3.2.2 Product B
        9.3.3 Bharat Biotech Human Vaccines Sales, Revenue, Price and Gross Margin (2012-2017)
        9.3.4 Main Business/Business Overview
    9.4 CSL Limited
        9.4.1 Company Basic Information, Manufacturing Base and Competitors
        9.4.2 Human Vaccines Product Category, Application and Specification
            9.4.2.1 Product A
            9.4.2.2 Product B
        9.4.3 CSL Limited Human Vaccines Sales, Revenue, Price and Gross Margin (2012-2017)
        9.4.4 Main Business/Business Overview
    9.5 Emergent BioSolutions, Inc.
        9.5.1 Company Basic Information, Manufacturing Base and Competitors
        9.5.2 Human Vaccines Product Category, Application and Specification
            9.5.2.1 Product A
            9.5.2.2 Product B
        9.5.3 Emergent BioSolutions, Inc. Human Vaccines Sales, Revenue, Price and Gross Margin (2012-2017)
        9.5.4 Main Business/Business Overview
    9.6 GlaxoSmithKline plc
        9.6.1 Company Basic Information, Manufacturing Base and Competitors
        9.6.2 Human Vaccines Product Category, Application and Specification
            9.6.2.1 Product A
            9.6.2.2 Product B
        9.6.3 GlaxoSmithKline plc Human Vaccines Sales, Revenue, Price and Gross Margin (2012-2017)
        9.6.4 Main Business/Business Overview
    9.7 Johnson & Johnson
        9.7.1 Company Basic Information, Manufacturing Base and Competitors
        9.7.2 Human Vaccines Product Category, Application and Specification
            9.7.2.1 Product A
            9.7.2.2 Product B
        9.7.3 Johnson & Johnson Human Vaccines Sales, Revenue, Price and Gross Margin (2012-2017)
        9.7.4 Main Business/Business Overview
    9.8 Merck & Co., Inc.
        9.8.1 Company Basic Information, Manufacturing Base and Competitors
        9.8.2 Human Vaccines Product Category, Application and Specification
            9.8.2.1 Product A
            9.8.2.2 Product B
        9.8.3 Merck & Co., Inc. Human Vaccines Sales, Revenue, Price and Gross Margin (2012-2017)
        9.8.4 Main Business/Business Overview
    9.9 Mymetics
        9.9.1 Company Basic Information, Manufacturing Base and Competitors
        9.9.2 Human Vaccines Product Category, Application and Specification
            9.9.2.1 Product A
            9.9.2.2 Product B
        9.9.3 Mymetics Human Vaccines Sales, Revenue, Price and Gross Margin (2012-2017)
        9.9.4 Main Business/Business Overview
    9.10 Novartis AG
        9.10.1 Company Basic Information, Manufacturing Base and Competitors
        9.10.2 Human Vaccines Product Category, Application and Specification
            9.10.2.1 Product A
            9.10.2.2 Product B
        9.10.3 Novartis AG Human Vaccines Sales, Revenue, Price and Gross Margin (2012-2017)
        9.10.4 Main Business/Business Overview
    9.11 Pfizer, Inc.
    9.12 Sanofi
    9.13 Shenzhen Kangtai Biological Products Co., Ltd.
    9.14 Takeda Pharmaceutical Company Limited.

10 Human Vaccines Maufacturing Cost Analysis
    10.1 Human Vaccines Key Raw Materials Analysis
        10.1.1 Key Raw Materials
        10.1.2 Price Trend of Key Raw Materials
        10.1.3 Key Suppliers of Raw Materials
        10.1.4 Market Concentration Rate of Raw Materials
    10.2 Proportion of Manufacturing Cost Structure
        10.2.1 Raw Materials
        10.2.2 Labor Cost
        10.2.3 Manufacturing Process Analysis of Human Vaccines
    10.3 Manufacturing Process Analysis of Human Vaccines

11 Industrial Chain, Sourcing Strategy and Downstream Buyers
    11.1 Human Vaccines Industrial Chain Analysis
    11.2 Upstream Raw Materials Sourcing
    11.3 Raw Materials Sources of Human Vaccines Major Manufacturers in 2016
    11.4 Downstream Buyers

12 Marketing Strategy Analysis, Distributors/Traders
    12.1 Marketing Channel
        12.1.1 Direct Marketing
        12.1.2 Indirect Marketing
        12.1.3 Marketing Channel Development Trend
    12.2 Market Positioning
        12.2.1 Pricing Strategy
        12.2.2 Brand Strategy
        12.2.3 Target Client
    12.3 Distributors/Traders List

13 Market Effect Factors Analysis
    13.1 Technology Progress/Risk
        13.1.1 Substitutes Threat
        13.1.2 Technology Progress in Related Industry
    13.2 Consumer Needs/Customer Preference Change
    13.3 Economic/Political Environmental Change

14 Global Human Vaccines Market Forecast (2017-2022)
    14.1 Global Human Vaccines Sales Volume, Revenue and Price Forecast (2017-2022)
       14.1.1 Global Human Vaccines Sales Volume and Growth Rate Forecast (2017-2022)
       14.1.2 Global Human Vaccines Revenue and Growth Rate Forecast (2017-2022)
       14.1.3 Global Human Vaccines Price and Trend Forecast (2017-2022)
    14.2 Global Human Vaccines Sales Volume, Revenue and Growth Rate Forecast by Region (2017-2022)
       14.2.1 Global Human Vaccines Sales Volume and Growth Rate Forecast by Regions (2017-2022)
       14.2.2 Global Human Vaccines Revenue and Growth Rate Forecast by Regions (2017-2022)
       14.2.3 United States Human Vaccines Sales Volume, Revenue and Growth Rate Forecast (2017-2022)
       14.2.4 China Human Vaccines Sales Volume, Revenue and Growth Rate Forecast (2017-2022)
       14.2.5 Europe Human Vaccines Sales Volume, Revenue and Growth Rate Forecast (2017-2022)
       14.2.6 Japan Human Vaccines Sales Volume, Revenue and Growth Rate Forecast (2017-2022)
       14.2.7 Southeast Asia Human Vaccines Sales Volume, Revenue and Growth Rate Forecast (2017-2022)
       14.2.8 India Human Vaccines Sales Volume, Revenue and Growth Rate Forecast (2017-2022)
    14.3 Global Human Vaccines Sales Volume, Revenue and Price Forecast by Type (2017-2022)
       14.3.1 Global Human Vaccines Sales Forecast by Type (2017-2022)
       14.3.2 Global Human Vaccines Revenue Forecast by Type (2017-2022)
       14.3.3 Global Human Vaccines Price Forecast by Type (2017-2022)
    14.4 Global Human Vaccines Sales Volume Forecast by Application (2017-2022)

15 Research Findings and Conclusion

16 Appendix
    16.1 Methodology/Research Approach
        16.1.1 Research Programs/Design
        16.1.2 Market Size Estimation
        16.1.3 Market Breakdown and Data Triangulation
    16.2 Data Source
        16.2.1 Secondary Sources
        16.2.2 Primary Sources
    16.3 Disclaimer